Placebo responses in patients with gastrointestinal disorders
- PMID: 17659688
- PMCID: PMC4146777
- DOI: 10.3748/wjg.v13.i25.3425
Placebo responses in patients with gastrointestinal disorders
Abstract
Over the last several years there has been a growing interest in placebo, not only as an inert control in clinical trials, but also in the placebo effect as a group effect as well as a reaction in individual subjects. Methodological factors such as regression to the mean and natural history of the disease play a role in the evaluation of a possible placebo effect. In this report, we discuss several factors including Pavlovian conditioning, beliefs outcome, expectations, and other factors as potential mediators of the placebo response. Placebo effects are common in gastrointestinal diseases and there seems to be no clear difference between placebo effects in functional gastrointestinal diseases (functional dyspepsia and irritable bowel syndrome) and organic gastrointestinal disease (duodenal ulcer and inflammatory bowel disease).
Figures
References
-
- Hoffman GA, Harrington A, Fields HL. Pain and the placebo: what we have learned. Perspect Biol Med. 2005;48:248–265. - PubMed
-
- Finniss DG, Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain. 2005;114:3–6. - PubMed
-
- Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci. 2005;6:545–552. - PubMed
-
- Linde K. The specific placebo effect. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006;49:729–735. - PubMed
-
- Klosterhalfen S, Enck P. Psychobiology of the placebo response. Auton Neurosci. 2006;125:94–99. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
